Thrombin-activatable fibrinolysis inhibitor (TAFI) levels and its polymorphism rs3742264 are associated with dyslipidemia in a cohort of Brazilian subjects

✍ Scribed by Santos, Izabela R.; Fernandes, Ana P.; Carvalho, Maria G.; Sousa, Marinez O.; Ferreira, Cláudia N.; Gomes, Karina B.

• Book ID: 125438309
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 616 KB
• Volume: 433
• Category: Article
• ISSN: 0009-8981
• DOI: 10.1016/j.cca.2014.02.030